Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bladder instillation without triamcinolone acetonide is a specific combination therapy administered directly into the bladder for treating interstitial cystitis/bladder pain syndrome (IC/BPS). The standard solution contains: - **Heparin**: A glycosaminoglycan that may help repair the bladder's protective lining - **Viscous lidocaine**: A local anesthetic that provides pain relief - **Sodium bicarbonate**: A buffering agent that helps optimize the pH of the solution - **Bupivacaine**: Another local anesthetic for pain management This formulation specifically excludes triamcinolone acetonide, which is sometimes included in other bladder instillation cocktails. This therapy is administered through catheterization, with the solution being held in the bladder for approximately 20-30 minutes. Clinical studies have shown that this instillation solution can improve symptoms associated with interstitial cystitis-bladder pain syndrome, as measured by a decrease in the O'Leary-Sant (OLS) questionnaire score. The treatment is typically administered as a series of instillations, with patients in clinical trials receiving six bladder instillations. According to the American Urological Association's clinical guidelines, bladder instillations are indicated as a treatment option when diet modification, stress management, and over-the-counter products are not sufficient for managing IC/BPS symptoms. For heparin specifically, when used as part of these instillations, a solution of 10,000 units diluted with saline solution is typically instilled daily and held in the bladder for 20-30 minutes. Patients can be taught to self-catheterize and administer treatments at home. After 3-4 months, the frequency may be reduced to 3-4 times per week.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bladder instillation without triamcinolone acetonide.